Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV – Yahoo Finance

Presentation on Tuesday, October 25 at 12:30 PM Pacific Time (3:30 PM Eastern)
Oxnard, California–(Newsfile Corp. – October 24, 2022) – Cure Pharmaceutical Holding Corp. (OTCQB: CURR) (“CURE”), a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems, announced today that it will be presenting at the 12th annual Invitational on Tuesday October 25 at 12:30 PM Pacific Time (3:30 PM Eastern) at the Luxe Sunset Boulevard Hotel. Nancy Duitch, CEO will be giving the presentation.
“15 years ago, we set out to create an event that could benefit our entire industry. It wasn’t fast or easy, but we were honorable in our dealings, and worked our tails off to ensure a wonderful time for everyone involved. Today, our community could not be larger, stronger, and more united, as we go through these difficult and turbulent times together. The Main Event is about learning, connecting, and enjoying each other, and it is a hell of a lot more fun than sitting next to your computer,” stated Chris Lahiji, Founder of LD Micro.
“As part of our renewed commitment to shareholder value and investor communication, we are really looking forward to the LD Micro conference as an opportunity to unveil to investors our new company identity and rebranding strategy and give some more details about our high margin revenue growth strategy, continued progress on additional non-dilutive deals and continued development of new products and patents,” stated Nancy Duitch, CEO of CURE. “Since the announcement of our $20 million non-dilutive deal and significantly positive management and Board of Director additions this summer, our team has been working diligently on several initiatives aligned with our guiding vision of enhancing shareholder value and on utilizing our proprietary technology that differentiates us from our competition, producing quality high-margin products with improved safety, efficacy, and consumer experience. We are really looking forward to having our senior executives and some board members interact with our investors and prospective investors during the presentation, one on one meetings and conference social events. We would also like to encourage those investors who cannot attend in person to watch the presentation virtually by registering free at the link below to watch live.”
Event: LD Micro Main Event XV
Date: Tuesday October 25
Time: at 12:30 PM Pacific Time (3:30 PM Eastern)
Register to watch the virtual presentation here.
Summary of LD Micro Main Event XV
The 2022 LD Micro Main Event XV will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from October 25th to the 27th.
The festivities will run from 7:30 AM PT – 5:30 PM PT on the 25th and 26th, with a half day on Thursday the 27th.
This three-day, investor conference is expected to feature around 200+ companies, presenting in half-hour increments, as well as private meetings.
For more info, please contact Mr. Dean “The Dream” Summers. Dean@ldmicro.com
About Cure Pharmaceutical Holding Corp.
Cure Pharmaceutical Holding Corp. is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that will be part of its incubator strategy in order to monetize its IP. As a vertically integrated platform company, CURE looks to partner or license its IP technology with wellness companies worldwide.
About LD Micro
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD’s sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.
http://www.ldmicro.com
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as “anticipate,” “believe,” “could,” “estimate,” “expected,” “intend,” “may,” “plan,” “predict,” “project,” “should,” “will,” or “would,” and similar expressions or the negative of these expressions.
Forward-looking statements represent our management’s current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information
Contacts:
Investor Relations
Hanover International Inc.
investor@curepharmaceutical.com
(760) 564-7400
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/141493
Related Quotes
DEEP DIVE Investors have made one thing clear: They don’t like Xi Jinping’s moves to consolidate power. Over the weekend, Xi took his third term as China’s communist party leader while sidelining rivals, extending his rule without an heir apparent.
Shares of many Chinese companies are getting hit hard today, including several of China's electric vehicle (EV) makers. Shares of Nio (NYSE: NIO), XPeng (NYSE: XPEV), and Li Auto (NASDAQ: LI) all plunged by double digits Monday morning. As of 10:53 a.m. ET, Nio shares were down 20.6%, XPeng was lower by 18.8%, and Li Auto had plunged 24.1%.
Amazon's (AMZN) third-quarter results are expected to reflect strength across its Prime and cloud businesses despite headwinds.
Wall Street's skepticism continues to feed Main Street's fears about this growth stock's prospects.
THE MONEYIST Dear Quentin,  I am a senior citizen and have suffered major losses to the tune of $100,000 in the recent stock market turmoil. Can I sue my financial adviser? I understand the dynamics of the market as far as its ups and downs, and have ridden them out before.
Considering the tough macro environment and its impact on the markets, investors can be forgiven for some indecision when it comes to choosing stocks right now. But there are clues, hints that will point out the right stocks, even in an unsettled market. The simplest move, of course, is to look for quality stocks that have fallen sharply in recent months, down to bargain-level prices. The adage is 'buy low and sell high,' and fundamentally sound stocks that have fallen 50% or more in less than a
In this article, we will look at the 10 most undervalued value stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Most Undervalued Value Stocks To Buy Now. 2022 has been an unfavorable year for stocks so far due to rampant inflation and high interest […]
AGNC Investment (AGNC) delivered earnings and revenue surprises of 18.31% and 38.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
But Wood's flagship Ark Innovation ETF has tumbled 63% so far this year, dropping 78% from its February 2021 peak.
Southern Copper Corporation ( NYSE:SCCO ) has announced that on 23rd of November, it will be paying a dividend of$0.50…
Kinder Morgan (NYSE: KMI) is the undisputed leader in natural gas infrastructure. The company owns and operates 70,000 miles of pipelines, giving it the largest natural gas network in North America. It transports 40% of the natural gas consumed in the U.S. each day.
KeyBanc analyst Josh Beck lowered his price target on Shopify from $50 to $45 while simultaneously maintaining his overweight (buy) rating on the stock, according to The Fly. The analyst has been reading the digital tea leaves and studying various proxies for Shopify's gross merchandise volume (GMV) and gross payment volume (GPV) — the most widely followed measures of the company's success. While Shopify's growth is certainly worth watching, it's best if we wait to hear the actual number from the company rather than relying on estimates.
Technology Equity Portfolio Manager at Jennison Associates Erika Klauer joins Yahoo Finance Live to discuss Big Tech earnings, the slowdown in digital advertising, and why Apple continues to dominate.
This year we saw declines pretty much across the board, with the S&P 500 tumbling ~20%. But last week was the index’s best week since June – the S&P had a weekly gain of about 4.7%. We’ve seen several of these bounces this year, and the question is, are they bullish indicators or merely 'dead cats'? According to Oppenheimer’s chief investment strategist John Stoltzfus, it shouldn't really make a difference whether we’re looking at bullish indicators or bear market rallies. The key here is simply
Shares of the online car marketplace Carvana (NYSE: CVNA) were tumbling today, despite market indexes making gains. Carvana's stock may have been falling as investors continue to process a price target cut from an analyst on Friday. Additionally, investors are likely concerned that high inflation and a potentially slowing economy could negatively impact the company's quarterly results, which will be reported next week.
Shares of Starbucks (NASDAQ: SBUX) fell on Monday, as investors wrestled with the ramifications of China's health and economic policies on the coffeehouse leader's growth prospects. COVID-related lockdowns in China have taken a heavy toll on Starbucks' sales and profits. The restaurant chain's comparable store sales plunged 44% in China in its fiscal third quarter ended July 3.
Alphabet has struggled to exceed quarterly estimates as of late, falling short of the Zacks Consensus EPS and Sales Estimates in back-to-back quarters.
A consolidation of power by President Xi alarms investors that have already faced down years of political and regulatory risk from China.
The average of price targets set by Wall Street analysts indicates a potential upside of 27.4% in Energy Transfer LP (ET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Advanced Micro Devices (AMD) closed the most recent trading day at $58.70, moving -0.2% from the previous trading session.

source